A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer vaccine, when combined with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback